12.35
Finanzdaten der Oric Pharmaceuticals Inc-Aktie (ORIC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
14.33%
45.30
|
39.62 | 34.55 | 36.67 | 39.06 |
| Operating Income/Loss |
14.33%
-45.30
|
-39.62 | -34.55 | -36.67 | -39.06 |
| Nonoperating Income/Loss |
1.25%
3.804
|
3.852 | 4.046 | 4.084 | 2.709 |
| Net Income/Loss |
16.01%
-41.49
|
-35.77 | -30.50 | -32.59 | -36.35 |
| Basic Average Shares |
2.41%
108.01
|
105.47 | 4.9848 | 98.95 | 78.13 |
| Diluted Average Shares |
2.41%
108.01
|
105.47 | 4.9848 | 98.95 | 78.13 |
| Basic Earnings Per Share |
11.76%
-0.38
|
-0.34 | -0.27 | -0.33 | -0.47 |
| Diluted Earnings Per Share |
11.76%
-0.38
|
-0.34 | -0.27 | -0.33 | -0.47 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):